Your session is about to expire
← Back to Search
Neurofeedback for Attention Deficit Hyperactivity Disorder (ADHD)
N/A
Waitlist Available
Led By Hadi Hosseini
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 weeks
Awards & highlights
Study Summary
This trial will test a new intervention that uses computer training, brain monitoring, and feedback to improve working memory in children with ADHD.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Target Frontal-parietal Activity
Change in Working Memory Performance
Secondary outcome measures
Change in Behavior Rating Inventory of Executive Function (BRIEF), Working Memory T-score
Change in Conners 3rd Edition ADHD Index Score
Change in Conners 3rd Edition Inattention T-score
+2 moreOther outcome measures
Change in California Verbal Learning Test - Children's Version (CVLT-C) Score
Change in Continuous Performance Test (CPT) Accuracy
Change in Parent Stress Index 4th Edition (PSI-IV)
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: NeurofeedbackExperimental Treatment1 Intervention
The Neurofeedback group will receive 12 sessions of computerized cognitive intervention combined with neurofeedback in the lab.
Group II: Cognitive TrainingActive Control1 Intervention
The Cognitive Training group will receive 12 sessions of computerized cognitive intervention in the lab.
Group III: WaitlistActive Control1 Intervention
Both Neurofeedback and Cognitive Training groups will be assigned to waitlist before starting the corresponding intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurofeedback
2019
Completed Phase 3
~1030
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,555 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
34 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
National Institute of Mental Health (NIMH)NIH
2,785 Previous Clinical Trials
2,689,691 Total Patients Enrolled
94 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
19,980 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Hadi HosseiniPrincipal Investigator - Stanford University
Stanford University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Illinois
Florida
Pennsylvania
Other
How old are they?
< 18
18 - 65
What site did they apply to?
Stanford University School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Share this study with friends
Copy Link
Messenger